Parishin CCAS# 174972-80-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 174972-80-6 | SDF | Download SDF |
PubChem ID | 10676408 | Appearance | White powder |
Formula | C32H40O19 | M.Wt | 728.7 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Solubility | Soluble in methan | ||
Chemical Name | 2-hydroxy-4-oxo-2-[2-oxo-2-[[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]ethyl]-4-[[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]butanoic acid | ||
SMILES | C1=CC(=CC=C1COC(=O)CC(CC(=O)OCC2=CC=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)(C(=O)O)O)OC4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | PMVCHAWVCIWVLP-KDSCYBBXSA-N | ||
Standard InChI | InChI=1S/C32H40O19/c33-11-19-23(37)25(39)27(41)29(50-19)48-17-5-1-15(2-6-17)13-46-21(35)9-32(45,31(43)44)10-22(36)47-14-16-3-7-18(8-4-16)49-30-28(42)26(40)24(38)20(12-34)51-30/h1-8,19-20,23-30,33-34,37-42,45H,9-14H2,(H,43,44)/t19-,20-,23-,24-,25+,26+,27-,28-,29-,30-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Parishin C can prevent vascular dementia. 2. Parishin C has antipsychotic effects, requires activation of 5-HT(1A) receptors. |
Targets | VEGFR | 5-HT Receptor |
Parishin C Dilution Calculator
Parishin C Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.3723 mL | 6.8615 mL | 13.7231 mL | 27.4461 mL | 34.3077 mL |
5 mM | 0.2745 mL | 1.3723 mL | 2.7446 mL | 5.4892 mL | 6.8615 mL |
10 mM | 0.1372 mL | 0.6862 mL | 1.3723 mL | 2.7446 mL | 3.4308 mL |
50 mM | 0.0274 mL | 0.1372 mL | 0.2745 mL | 0.5489 mL | 0.6862 mL |
100 mM | 0.0137 mL | 0.0686 mL | 0.1372 mL | 0.2745 mL | 0.3431 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Parishin B
Catalog No.:BCN3812
CAS No.:174972-79-3
- Rabdoketone B
Catalog No.:BCN6598
CAS No.:174819-51-3
- 3-Amino-4-methoxybenzamide
Catalog No.:BCC8612
CAS No.:17481-27-5
- Fmoc-Hyp(Bzl)-OH
Catalog No.:BCC3255
CAS No.:174800-02-3
- Carabrone
Catalog No.:BCN1121
CAS No.:1748-81-8
- Ginsenoside Rh4
Catalog No.:BCN3503
CAS No.:174721-08-5
- 2-Amino-6-methoxybenzothiazole
Catalog No.:BCC8542
CAS No.:1747-60-0
- CH 275
Catalog No.:BCC5913
CAS No.:174688-78-9
- AN-2690
Catalog No.:BCC1360
CAS No.:174671-46-6
- Phalloidin
Catalog No.:BCC7945
CAS No.:17466-45-4
- Talnetant
Catalog No.:BCC1981
CAS No.:174636-32-9
- SB-222200
Catalog No.:BCC1926
CAS No.:174635-69-9
- Tonabersat
Catalog No.:BCC2009
CAS No.:175013-84-0
- NQDI 1
Catalog No.:BCC2404
CAS No.:175026-96-7
- O4I1
Catalog No.:BCC6542
CAS No.:175135-47-4
- Xanthorin
Catalog No.:BCN1122
CAS No.:17526-15-7
- Fmoc-Thr(HPO3Bzl)-OH
Catalog No.:BCC3551
CAS No.:175291-56-2
- S 18986
Catalog No.:BCC6081
CAS No.:175340-20-2
- Voreloxin
Catalog No.:BCC2044
CAS No.:175414-77-4
- Z-Phe(4-F)-OH
Catalog No.:BCC3221
CAS No.:17543-58-7
- Eriosematin A
Catalog No.:BCN3465
CAS No.:175448-02-9
- Fmoc-3-Pal-OH
Catalog No.:BCC2653
CAS No.:175453-07-3
- Fmoc-Phe(4-Cl)-OH
Catalog No.:BCC3173
CAS No.:175453-08-4
- Voreloxin Hydrochloride
Catalog No.:BCC2045
CAS No.:175519-16-1
Study on active ingredient and mechanism in preventing vascular dementia of Tianzhusan coming from Tujia medicine.[Pubmed:26697697]
Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(13):2668-73.
To make clear of the absorbed components of Tianzhusan (TZS) and its possible mechanism in preventing vascular dementia (VD), the rats' models of VD were prepared by a permanent ligation of the bilateral common carotid arteries. After 60 days, rats were administrated with TZS for 0.1 g x kg(-1), and the volume is 0.02 mL x g(-1). After 3 days, the medicated serum was prepared and detected by UPLC, and then we predicted the possible chemical structure of the absorbed components of TZS. According to the absorbed components, the potential targets of TZS were found by ligand profiling of Discovery Studio 3.5. All of these target genes were submitted to DAVID onine for gene set enrichment analysis (GSEA). The 5 absorbed components of TZS have been predicted, and four of them have been identified as parishin B, Parishin C, parishin, pennogenin-3-O-alpha-L-rhamnopyranosy-(1-->2)-beta-D-glucoside. Through reverse finding targets, we got 861 pharmacophore models and 9 pathways from KEGG, BIOCARTA after document verification. These results showed that the efficacy mechanism of TZS on VD perhaps were be related with these absorbed components and pathways. If the traditional herbs could be proved effective by efficacy tests, the serum pharmacochemistry, computer-aided drug design, system biology and other technologies can be used in the next experiments, which will be beneficial to fast discovery of material basis and mechanisms of traditional medicine coming form ethnic minorities.
Parishin C attenuates phencyclidine-induced schizophrenia-like psychosis in mice: involvements of 5-HT1A receptor.[Pubmed:20644336]
J Pharmacol Sci. 2010;113(4):404-8. Epub 2010 Jul 13.
Parishin C, a major component of Gastrodia elata BLUME (GE), was purified from GE. Because GE modulates the serotonergic system and the 5-HT(1A) receptor is an important therapeutic target of schizophrenia, we examined whether Parishin C affects phencyclidine-induced abnormal behaviors in mice. Phencyclidine-induced abnormal behaviors were significantly ameliorated by Parishin C. These effects were reversed by WAY 100635, a 5HT(1A)-receptor antagonist. Consistently, Parishin C showed high affinity at 5-HT(1A) receptor as well as a 5-HT(1A)-agonist activity in a 8-OH-DPAT-stimulated [(35)S]GTP-gammaS binding assay. Our results suggest that the antipsychotic effects of Parishin C require activation of 5-HT(1A) receptors.